Zimbabwe has declined a major American health deal valued at $367m (£272m) over five years because of the United States' request for confidential data.
The decision was revealed following a internal memorandum dated December was leaked, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since stated that the United States was demanding access to biological samples for research and commercial purposes but refused to guarantee the benefits from future medical innovations.
"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged more negotiations to secure a agreement suitable to all parties so the country's vital HIV treatment initiative can continue.
Broader Context
This rejection comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost transparency and responsibility.
According to reports, 16 African countries have to date signed these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to provide its biological resources and data for a long time, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for medical research with no certainty that the final treatments would be accessible to our population should a future health crisis emerge."
Sovereignty and Global Health
He also said that the American exit from the global health body and its push of bilateral health agreements were upending frameworks previously set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future pandemics.
"This mechanism is designed to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the funds to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued dialogue with our American counterparts on how future collaboration could be structured in a manner that respects the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that negotiations must proceed since a large portion of the country's Aids initiatives relied on international support.
"In cases where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," the group said.
This impasse underscores the complex tensions between accepting much-needed foreign assistance and protecting a country's data in an ever more data-driven world.